Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Digital repository of Slovenian research organisations
About
Search
Browse
Statistics
Contacts
Login
Show document
A+
|
A-
|
|
SLO
|
ENG
Title:
Novosti pri obravnavi bolnikov z malignim melanomom
Authors:
ID
Hočevar, Marko
(Author)
Files:
PDF - Presentation file,
download
(107,50 KB)
MD5: 017B52B5B78A69A1466779F45E6AB2AF
PID:
20.500.12556/dirros/630b6be4-09f7-4067-bed4-db45ee769024
Language:
Slovenian
Typology:
1.04 - Professional Article
Organization:
OI - Institute of Oncology
Publication status:
Published
Publication version:
Version of Record
Year of publishing:
2001
Number of pages:
str. 8-10
Numbering:
Letn. 5, št. 1
PID:
20.500.12556/DiRROS-9013
UDC:
616-006
ISSN on article:
1408-1741
URN:
URN:NBN:SI:doc-C8OU6R0A
COBISS.SI-ID:
13524953
Copyright:
by Authors
Note:
BSDOCID82414;
Publication date in DiRROS:
31.08.2018
Views:
3303
Downloads:
648
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
HOČEVAR, Marko, 2001, Novosti pri obravnavi bolnikov z malignim melanomom.
Onkologija
[online]. 2001. Vol. 5, no. 1, p. 8–10. [Accessed 8 April 2025]. Retrieved from: https://dirros.openscience.si/IzpisGradiva.php?lang=eng&id=9013
Copy citation
Share:
Similar works from our repository:
Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN)
Trans-esophageal endobronchial ultrasound-guided needle aspiration (EUS-B-NA)
Access to novel drugs for non-small cell lung cancer in Central and Southeastern Europe
Similar works from other repositories:
Vpliv izražanja receptorja za inzulinu podoben rastni dejavnik 1 (IGF1R) na preživetje pri razsejanem nedrobnoceličnem raku pljuč
Gene expression levels of the prolyl hydroxylase domain proteins PHD1 and PHD2 but not PHD3 are decreased in primary tumours and correlate with poor prognosis of patients with surgically resected non-small-cell lung cancer
Usefulness of immunohistochemically determined epidermal growth factor receptor mutations in lung cancer
Systematic review of observational studies evaluating the effectiveness and safety of immune checkpoint inhibitors in patients with metastatic non-small-cell lung cancer
ǂThe ǂimportance of cancer stem cells and epithelial-mesenchymal transition in the progression of non-small cell lung cancer
Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.
Record is a part of a journal
Title:
Onkologija
Shortened title:
Onkologija
Publisher:
Onkološki inštitut
ISSN:
1408-1741
COBISS.SI-ID:
65324032
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:
31.08.2018
Archive
niGradiv
Back